DRAFT TRANSLATION · REVIEW PENDING
COMPANY
COMPANY · HAEPAGEN
COMPANY OVERVIEW
From an ocean challenge to a future bio-industry
We transform jellyfish overpopulation into high-purity, functional atelocollagen biomaterials.
Marine Resource
Turning an ocean challenge into future value
Atelocollagen
High-purity, low-immunogenicity biomaterial
Bio Platform
Expanding across beauty, health and regenerative research
NEXT-GENERATION MARINE BIOTECH
Turning an ocean challenge into a high-value bio-industry.
HAEPAGEN Co., Ltd. is an ESG-driven next-generation biotech platform connecting jellyfish overpopulation with high-purity, functional atelocollagen.
We transform an underused marine resource into industrial value and build an integrated biomaterial platform spanning research, manufacturing and product applications.
CORE COMPETITIVENESS
HAEPAGEN collagen technology leading the global market
HAEPAGEN: Leading the Global Market with Advanced Collagen Technology
- 01Korea's First Facility
A B-GMP-based production system for jellyfish collagen biomaterials
- 02World-Class Technology
Biomaterial production completed with advanced electron-beam technology
- 03Streamlined Manufacturing
Innovative technology designed to reduce production costs
- 04Biomaterial Safety
Safe biomaterial production based on patented electron-beam processing
- 05Advanced Technology
Proprietary high-purity separation and low-molecular-weight processing
- 06ESG Environmental Company
An ESG company advancing a sustainable marine ecosystem
CORE MATERIAL
High-purity jellyfish-derived atelocollagen
HAEPAGEN precisely removes immunogenic telopeptides to minimize immune response. Its patented, streamlined extraction process is designed to improve productivity and cost competitiveness while expanding the potential of highly biocompatible derma and biomaterial applications.
- Ocean challengeJellyfish overpopulation
- Precision processingPatented extraction
- Pure atelocollagenLow-immunogenicity material
- Integrated platformCross-industry expansion
BUSINESS PLATFORM
One material platform, three industries
From core material R&D and manufacturing, HAEPAGEN is expanding into premium cosmetics, nutraceuticals and regenerative biomaterials.
- COSMETICSPremium Cosmetics
Functional derma and skincare solutions including ampoules, serums, masks and creams
- NUTRACEUTICALSInner Beauty & Health
Collagen drinks, capsules and stick-type health formats
- MEDICAL / BIORegenerative Biomaterials
Phased research into hydrogels, tissue recovery, wound care, hemostats and drug delivery
VISION & CORE VALUES
Leading healthier lives through sustainable biotechnology.
We connect innovative material development, responsible manufacturing and marine ecosystem value with a long-term biotechnology platform.
- Innovation
Creating value through proprietary technology
- Trust
Building lasting trust with clients and partners
- Sustainability
Following eco-conscious manufacturing processes
COMPANY AT A GLANCE
HAEPAGEN Overview
- Company
- HAEPAGEN Co., Ltd.
- CEO
- Dongho Ki
- Business
- Biomaterial R&D · Raw material manufacturing · Cosmetics manufacturing
- Core Platform
- Next-generation jellyfish-derived atelocollagen biomaterials
- Business Base
- Gwangju headquarters and R&D center · Planned Hwasun BGMP facility